These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8191092)

  • 1. [Encephalopathy and memory disorders during treatments with mefloquine].
    Marsepoil T; Petithory J; Faucher JM; Ho P; Viriot E; Benaiche F
    Rev Med Interne; 1993; 14(8):788-91. PubMed ID: 8191092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
    Lebain P; Juliard C; Davy JP; Dollfus S
    Encephale; 2000; 26(4):67-70. PubMed ID: 11064842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports.
    Ringqvist Å; Bech P; Glenthøj B; Petersen E
    Travel Med Infect Dis; 2015; 13(1):80-8. PubMed ID: 25435322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Murai Z; Baran B; Tolna J; Szily E; Gazdag G
    Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
    Tran TM; Browning J; Dell ML
    Malar J; 2006 Aug; 5():74. PubMed ID: 16925829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spectacular suicide associated with mefloquine].
    Jousset N; Guilleux M; de Gentile L; Le Bouil A; Turcant A; Rougé-Maillart C
    Presse Med; 2006 May; 35(5 Pt 1):789-92. PubMed ID: 16710147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute psychosis after mefloquine. Report of six cases.
    Sowunmi A; Adio RA; Oduola AM; Ogundahunsi OA; Salako LA
    Trop Geogr Med; 1995; 47(4):179-80. PubMed ID: 8560592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
    Clattenburg RN; Donnelly CL
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood mefloquine-induced mania and psychosis: a case report.
    Thapa R; Biswas B
    J Child Neurol; 2009 Aug; 24(8):1008-9. PubMed ID: 19295181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].
    Meszaros K; Kasper S
    Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism at the MDR1 locus as a cause of mefloquine-induced psychosis].
    Zaigraykina N; Potasman I
    Harefuah; 2010 Sep; 149(9):583-4, 620, 619. PubMed ID: 21302473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric side effects after the use of mefloquine.
    Weinke T; Trautmann M; Held T; Weber G; Eichenlaub D; Fleischer K; Kern W; Pohle HD
    Am J Trop Med Hyg; 1991 Jul; 45(1):86-91. PubMed ID: 1867351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.
    Bem JL; Kerr L; Stuerchler D
    J Trop Med Hyg; 1992 Jun; 95(3):167-79. PubMed ID: 1597872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
    Bygbjerg IC; Rønn AM
    Ugeskr Laeger; 1999 Mar; 161(10):1422-3. PubMed ID: 10085752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mefloquine-induced psychosis.
    Havaldar PV; Mogale KD
    Pediatr Infect Dis J; 2000 Feb; 19(2):166-7. PubMed ID: 10694009
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.
    Meier CR; Wilcock K; Jick SS
    Drug Saf; 2004; 27(3):203-13. PubMed ID: 14756582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.